| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |